Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[TARCEVA Clinical Registry].
Skricková J, Pesek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Krejcí J, Tomísková M, Grygárková Y, Havel L, Hrnciarik M, Skalová B, Stícha M. Skricková J, et al. Among authors: krejci j. Klin Onkol. 2010;23(5):361-3. Klin Onkol. 2010. PMID: 21061685 Czech. No abstract available.
[EGFR mutations in patients with advanced NSCLC].
Fiala O, Pešek M, Fínek J, Brůha F, Bortlíček Z, Krejčí J, Benešová L, Minárik M. Fiala O, et al. Among authors: krejci j. Klin Onkol. 2012;25(4):267-73. Klin Onkol. 2012. PMID: 22920167 Czech.
Erlotinib in the treatment of advanced squamous cell NSCLC.
Fiala O, Pesek M, Finek J, Krejci J, Havel L, Hrnciarik M, Salajka F, Bortlicek Z, Benesova L, Minarik M. Fiala O, et al. Among authors: krejci j. Neoplasma. 2013;60(6):676-82. doi: 10.4149/neo_2013_086. Neoplasma. 2013. PMID: 23906302
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn L, Steins M, Felip E, van den Heuvel MM, Ciuleanu TE, Badin F, Ready N, Hiltermann TJN, Nair S, Juergens R, Peters S, Minenza E, Wrangle JM, Rodriguez-Abreu D, Borghaei H, Blumenschein GR Jr, Villaruz LC, Havel L, Krejci J, Corral Jaime J, Chang H, Geese WJ, Bhagavatheeswaran P, Chen AC, Socinski MA; CheckMate 026 Investigators. Carbone DP, et al. Among authors: krejci j. N Engl J Med. 2017 Jun 22;376(25):2415-2426. doi: 10.1056/NEJMoa1613493. N Engl J Med. 2017. PMID: 28636851 Free PMC article.
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer.
Svaton M, Zemanova M, Zemanova P, Kultan J, Fischer O, Skrickova J, Jakubikova L, Cernovska M, Hrnciarik M, Jirousek M, Krejci J, Krejci D, Bilek O, Blazek J, Hurdalkova K, Barinova M, Melichar B. Svaton M, et al. Among authors: krejci d, krejci j. Anticancer Res. 2020 Apr;40(4):2209-2217. doi: 10.21873/anticanres.14182. Anticancer Res. 2020. PMID: 32234916
Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.
Brat K, Bratova M, Skrickova J, Barinova M, Hurdalkova K, Pesek M, Havel L, Koubkova L, Hrnciarik M, Krejci J, Fischer O, Zemanova M, Coupkova H, Svaton M. Brat K, et al. Among authors: krejci j. Thorac Cancer. 2020 Nov;11(11):3346-3356. doi: 10.1111/1759-7714.13679. Epub 2020 Oct 5. Thorac Cancer. 2020. PMID: 33016001 Free PMC article.
317 results